Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01270542 · ClinicalTrials.gov registry record · NA
Avastin for PDR (Proliferative Diabetic Retinopathy)
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01270542 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 20 participants.
The verdict
NCT01270542, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of anti-VEGF drug (Avastin) adminstration in eyes prior to surgical treatment for Traction retinal detachment (TRD) in patients with Proliferative Diabetic Retinopathy (PDR).
Interventions
- OTHER Sham injection
- DRUG Avastin (bevacizumab)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01270542
The ClinicalTrials.gov registry entry for NCT01270542 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham injection is the first listed.
NCT01270542 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01270542 about?
NCT01270542 is a clinical study titled "Avastin for PDR (Proliferative Diabetic Retinopathy)". The purpose of this study is to determine the effect of anti-VEGF drug (Avastin) adminstration in eyes prior to surgical treatment for Traction retinal detachment (TRD) in patients with Proliferative Diabetic Retinopathy (PDR).
What is the current status of trial NCT01270542?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2009-06. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01270542?
The interventions under investigation include: Sham injection (OTHER), Avastin (bevacizumab) (DRUG).
Who is sponsoring clinical trial NCT01270542?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.